Abbott delivers $12.6 billion second quarter sales
Abbott (NYSE:ABT) reported second-quarter 2026 sales of $12.6 billion and an adjusted earnings of $1.31 per diluted share.
Abbott (NYSE:ABT) reported second-quarter 2026 sales of $12.6 billion and an adjusted earnings of $1.31 per diluted share.
ManpowerGroup (NYSE:MAN) reported second-quarter 2026 revenues of $4.9 billion and net earnings of $53.5 million.
LCNB Corp. (NASDAQ:LCNB) reported a record second-quarter net income of $7.5 million and earnings of $0.53 per share for the three months ended June 30.
Moderna (NASDAQ:MRNA) dosed the first U.S. participant in its Phase 1 trial evaluating the mRNA-4200 cancer antigen therapy.
Main Street Capital (NYSE:MAIN) projected second-quarter distributable net investment income between $1.02 and $1.06 per share.
Horizon Aircraft (NASDAQ:HOVR) reported fiscal 2026 fourth-quarter results, highlighting a strengthened cash balance of $78.3 million.
Merck (NYSE:MRK) received FDA approval for Lipfendra 20 mg after a Phase 3 trial showed a 56% LDL-C reduction versus placebo.
U.S. Bancorp (NYSE:USB) reported Q1 2026 net revenue of $7.288 billion and diluted EPS of $1.18, exceeding the $1.14 analyst estimate.
Eli Lilly (NYSE:LLY) executed a definitive agreement to acquire AtaiBeckley (NASDAQ:ATAI) for a $2.8 billion upfront equity valuation.
Tether, the world's largest stablecoin issuer by market capitalisation, has invested US$20 million in Argentine digital bank Ualá as part of a broader push to expand its presence across South America.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy